Nexlife Review
Every compounded batch third-party tested for potency and sterility
Semaglutide from $139/month, tirzepatide from $169/month; FSA and HSA eligible
FDA action on record
FDA reviewed Nexlife's website at nexlife.us in March 2026 — the same site served at nexlife.com — and observed that it offers compounded semaglutide and tirzepatide products, stating that claims made about them were false or misleading.
- Entity: Nexlife Inc. dba Nexlife
- Action: FDA warning letter (MARCS-CMS 730096)
- Date: June 8, 2026
A warning letter is FDA's stated position that violations occurred. It is not a court finding, a recall, or a determination that any patient was harmed, and these letters concerned marketing claims about compounded GLP-1 products rather than a specific batch of medication. Companies often respond and correct the cited material. We publish this so you can weigh it yourself — read the letter and check the provider's current status before deciding.
Read the FDA letter on fda.gov →Overview
Nexlife's distinguishing feature is quality assurance rather than price, though the price is competitive: compounded semaglutide from $139/month and tirzepatide from $169/month, both FSA and HSA eligible with free expedited delivery. What sets it apart is that every compounded prescription is evaluated by independent third-party laboratories, with potency, sterility, pH and endotoxin testing published as part of the pharmacy's quality-control procedures — potency confirming documented concentration, sterility assessed against USP 797 standards, and pH checked to limit injection-site irritation. For a category where the central worry is what is actually in the vial, publishing that testing regime is a meaningful differentiator. Care runs through the Care 360 System: same-day virtual visits, smart health tracking, one-on-one guidance and around-the-clock care team access. Nexlife is candid in its own disclaimers that compounded medications are not FDA-approved and have not been reviewed for safety, effectiveness or quality, and that BMI alone does not determine eligibility.
Pros
- Publishes independent third-party testing for potency, sterility, pH and endotoxin on every batch
- Sterility testing referenced against USP 797 sterile compounding standards
- Competitive pricing — semaglutide from $139/month, tirzepatide from $169/month
- All plans FSA and HSA eligible
- Same-day virtual doctor visits and free expedited discreet shipping
- Unusually careful disclaimers about BMI limits and compounded status
Cons
- Compounded only — no brand-name Wegovy or Zepbound route
- Pharmacies are described as a network but not individually named
- State availability is not published
- Cancellation and refund terms are not published
- Lab requirements before starting are not specified
Key Features
Best For
Patients whose main worry about compounded GLP-1s is product quality rather than headline price
Nexlife at a Glance
Everything below reflects what Nexlife published on its own site as of August 23, 2026. Where a detail is not published, we say so rather than guessing.
- • Compounded semaglutide
- • Compounded tirzepatide
Pricing
Compounded semaglutide starts at $139/month and compounded tirzepatide at $169/month, described as transparent upfront pricing. All plans are FSA and HSA eligible and include free expedited discreet shipping. Nexlife does not publish a separate membership fee.
Membership fees
Not published on Nexlife's website at the time of review. Confirm directly with Nexlife before enrolling.
Medication fees
- • Compounded semaglutide: from $139/month
- • Compounded tirzepatide: from $169/month
- • Free expedited shipping included
Prices change often in this category. Always confirm the current cost — including what you will pay after any introductory or promotional period — directly with Nexlife before enrolling.
Cancellation, Refunds & Payment
Support Services
Limitations to Know
- Compounded products are not FDA-approved as finished drugs, as Nexlife states itself
- Network pharmacies are not individually named
- State availability, membership fees, cancellation and refund terms are not published
- No brand-name route if you would rather have Wegovy or Zepbound
Alternatives to Nexlife
Names both of its pharmacies outright and undercuts Nexlife on annual pricing.
Names six pharmacies and both prescribing physicians, with a $129 microdose tier.
Publishes a full tiered price ladder and its BMI eligibility criteria.
Still comparing? See our full ranking of online GLP-1 providers.
Nexlife FAQs
What does Nexlife's third-party testing actually cover?
Independent registered laboratories evaluate each compounded prescription for potency (confirming the documented concentration of active ingredients), sterility (assessed against USP 797 sterile compounding standards), pH (to limit injection-site irritation) and endotoxins.
How much does Nexlife cost?
Compounded semaglutide starts at $139/month and compounded tirzepatide at $169/month. All plans are FSA and HSA eligible and include free expedited discreet shipping.
Does Nexlife use my BMI to decide if I qualify?
Not on its own. Nexlife states plainly that its BMI calculator does not determine eligibility, and that a licensed provider must assess your full medical history to decide whether treatment may be appropriate.
Are Nexlife's medications FDA-approved?
No, and Nexlife says so directly. Its compounded semaglutide and tirzepatide are not approved by the FDA and have not been reviewed for safety, effectiveness or quality — which is why the third-party batch testing is the point of the offering.
Sources consulted
Medical disclaimer: This review is for educational and comparison purposes only and is not medical advice. Rx Saver Hub is not a medical provider and does not prescribe medication. Compounded medications are not FDA-approved, and the FDA does not evaluate their safety, effectiveness or quality. Program details, pricing and availability change frequently — verify everything directly with Nexlife. Always consult a qualified healthcare provider before starting, stopping or changing any weight-loss treatment. Individual results vary.
Nexlife
Semaglutide from $139/month, tirzepatide from $169/month; FSA and HSA eligible
Quick Stats
Share Your Experience
Help others by sharing your experience with Nexlife
User Reviews
No ratings yet
Rate your experience
Click a star to rate and add a review
Questions & Discussions
Ready to Get Started with Nexlife?
Join thousands of others who have started their weight loss journey with Nexlife.
Visit Nexlife